Compare TG Therapeutics Inc (TGTX) vs Workiva Inc (WK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Workiva Inc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Workiva Inc trades at $55.02 (market cap $3.21B). The key difference: TG Therapeutics Inc is far larger — about 2.6× Workiva Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.
| TGTX | WK | |
|---|---|---|
Market Cap | $8.26B | $3.21B |
Sector | Health | Technology |
52-Week High | $59.06 | $93.31 |
52-Week Low | $26.39 | $44.31 |
Enterprise Value | $8.50B | $3.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →
